selected publications
- Antimicrobial Peptide Pro10-1D Exhibits Anti-Allergic Activity: A Promising Therapeutic Candidate. International journal of molecular sciences. 2024 Academic Article GET IT
-
IL-10+ regulatory B cells mitigate atopic dermatitis by suppressing eosinophil activation.
Scientific reports.
2024
Academic Article
GET IT
Times cited: 4 - IL-27-induced PD-L1highSca-1+ innate lymphoid cells suppress contact hypersensitivity in an IL-10-dependent manner. Experimental & molecular medicine. 2024 Academic Article GET IT
- Epigenetic landscape analysis reveals the significance of early reduced chromatin accessibility in osteoclastogenesis. Bone. 2023 Academic Article GET IT
- Drug repositioning of anti-microbial agent nifuratel to treat mast cell-mediated allergic responses. International journal of immunopathology and pharmacology. 2023 Academic Article GET IT
-
AT9283, 1-Cyclopropyl-3-(3-(5-(Morpholinomethyl)-1H-Benzo[d]Imidazole-2-yl)-1H-Pyrazol-4-yl) Urea, Inhibits Syk to Suppress Mast Cell-Mediated Allergic Response.
Biomolecules & therapeutics.
2022
Academic Article
GET IT
Times cited: 3 -
CD1dhiPD-L1hiCD27+ Regulatory Natural Killer Subset Suppresses Atopic Dermatitis.
Frontiers in immunology.
2022
Academic Article
GET IT
Times cited: 6 -
Entinostat, a histone deacetylase inhibitor, increases the population of IL-10+ regulatory B cells to suppress contact hypersensitivity.
BMB reports.
2021
Academic Article
GET IT
Times cited: 6 -
Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation.
International journal of molecular sciences.
2021
Academic Article
GET IT
Times cited: 25 -
Glutamine metabolite α-ketoglutarate acts as an epigenetic co-factor to interfere with osteoclast differentiation.
Bone.
2020
Academic Article
GET IT
Times cited: 24 -
Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice.
Biomolecules & therapeutics.
2020
Academic Article
GET IT
Times cited: 18 -
WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo.
Toxicology and applied pharmacology.
2019
Academic Article
GET IT
Times cited: 15 -
The regulatory B cell-mediated peripheral tolerance maintained by mast cell IL-5 suppresses oxazolone-induced contact hypersensitivity.
Science advances.
2019
Academic Article
GET IT
Times cited: 26 -
An Anti-Cancer Drug Candidate CYC116 Suppresses Type I Hypersensitive Immune Responses through the Inhibition of Fyn Kinase in Mast Cells.
Biomolecules & therapeutics.
2019
Academic Article
GET IT
Times cited: 12 -
Repositioning of anti-cancer drug candidate, AZD7762, to an anti-allergic drug suppressing IgE-mediated mast cells and allergic responses via the inhibition of Lyn and Fyn.
Biochemical pharmacology.
2018
Academic Article
GET IT
Times cited: 18 -
Furaltadone suppresses IgE-mediated allergic response through the inhibition of Lyn/Syk pathway in mast cells.
European journal of pharmacology.
2018
Academic Article
GET IT
Times cited: 13 -
Polysaccharide isolated from Aloe vera gel suppresses ovalbumin-induced food allergy through inhibition of Th2 immunity in mice.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2018
Academic Article
GET IT
Times cited: 56 -
JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis.
BMB reports.
2017
Article
GET IT
Times cited: 25